RGNX
REGENXBIO Inc.
$9.06
+$0.17(+1.91%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$467.76M
Volume
420.90K
52W Range
$5.04 - $12.22
Target Price
$30.08
EPS Estimates Overview
| Current Quarter | $-1.38 | Next Quarter | $0.27 |
| Current Year | $-2.43 | Next Year | $-2.59 |
| QoQ Growth | +119.6% | YoY Growth | -6.6% |
| 3Y EPS CAGR | -52.2% | Target Price | $30.08 |
| Consensus | Buy | Upside | +232.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RGNX | $9.06 | +1.9% | 420.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |